The recent advent of genome editing techniques and their rapid improvement paved the way in establishing innovative human neurological disease models and in developing new therapeutic opportunities. Human pluripotent (both induced or naive) stem cells and neural stem cells represent versatile tools to be applied to multiple research needs and, together with genomic snip and fix tools, have recently made possible the creation of unique platforms to directly investigate several human neural affections. In this chapter, we will discuss genome engineering tools, and their recent improvements, applied to the stem cell field, focusing on how these two technologies may be pivotal instruments to deeply unravel molecular mechanisms underlying development and function, as well as disorders, of the human brain. We will review how these frontier technologies may be exploited to investigate or treat severe neurodevelopmental disorders, such as microcephaly, autism spectrum disorder, schizophrenia, as well as neurodegenerative conditions, including Parkinson's disease, Huntington's disease, Alzheimer's disease, and spinal muscular atrophy.

Genome editing in stem cells for genetic neurodisorders / Dell' Amico, C.; Tata, A.; Pellegrino, E.; Onorati, M.; Conti, L.. - In: PROGRESS IN MOLECULAR BIOLOGY AND TRANSLATIONAL SCIENCE. - ISSN 1877-1173. - ELETTRONICO. - 2021/182:(2021), pp. 403-438. [10.1016/bs.pmbts.2020.12.006]

Genome editing in stem cells for genetic neurodisorders

Tata A.;Conti L.
2021

Abstract

The recent advent of genome editing techniques and their rapid improvement paved the way in establishing innovative human neurological disease models and in developing new therapeutic opportunities. Human pluripotent (both induced or naive) stem cells and neural stem cells represent versatile tools to be applied to multiple research needs and, together with genomic snip and fix tools, have recently made possible the creation of unique platforms to directly investigate several human neural affections. In this chapter, we will discuss genome engineering tools, and their recent improvements, applied to the stem cell field, focusing on how these two technologies may be pivotal instruments to deeply unravel molecular mechanisms underlying development and function, as well as disorders, of the human brain. We will review how these frontier technologies may be exploited to investigate or treat severe neurodevelopmental disorders, such as microcephaly, autism spectrum disorder, schizophrenia, as well as neurodegenerative conditions, including Parkinson's disease, Huntington's disease, Alzheimer's disease, and spinal muscular atrophy.
Dell' Amico, C.; Tata, A.; Pellegrino, E.; Onorati, M.; Conti, L.
Genome editing in stem cells for genetic neurodisorders / Dell' Amico, C.; Tata, A.; Pellegrino, E.; Onorati, M.; Conti, L.. - In: PROGRESS IN MOLECULAR BIOLOGY AND TRANSLATIONAL SCIENCE. - ISSN 1877-1173. - ELETTRONICO. - 2021/182:(2021), pp. 403-438. [10.1016/bs.pmbts.2020.12.006]
File in questo prodotto:
File Dimensione Formato  
1-s2.0-S1877117320301769-main(1).pdf

Solo gestori archivio

Descrizione: Article in press
Tipologia: Versione editoriale (Publisher’s layout)
Licenza: Tutti i diritti riservati (All rights reserved)
Dimensione 755.58 kB
Formato Adobe PDF
755.58 kB Adobe PDF   Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11572/292623
Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus 3
  • ???jsp.display-item.citation.isi??? 2
social impact